期刊文献+

奥沙利铂联合氟尿嘧啶/亚叶酸钙时辰化疗治疗晚期胃肠道肿瘤的临床观察 被引量:4

A clinical study of chronomodulated chemotherapy of oxaliplatin, 5-fluorouracil and folinic acid regimen in the advanced gastrointestinal cancer
下载PDF
导出
摘要 目的:观察奥沙利铂联合氟尿嘧啶/亚叶酸钙(FFL方案)时辰输注法治疗晚期胃肠道肿瘤的近期疗效和毒性反应。方法:FFL方案时辰输注法治疗32例晚期胃肠道肿瘤患者,奥沙利铂25mg/(m^2·d)(10:00~22:00),氟尿嘧啶600mg/(m^2·d)(22:00~10:00),亚叶酸钙300mg/(m^2·d)(22:00~10:00),分别加5%葡萄糖液至200ml,通过四通道程控时辰输液泵连续给药5天,每21天为1个周期,至少用2个周期。根据世界卫生组织实体瘤化疗判定标准(1981)评价近期疗效。结果:32例患者中,完全缓解(CR)1例(3.1%),部分缓解(PR)14例(43.8%),稳定(SD)13例(40.6%),进展(PD)4例(12.5%),总有效率为46.9%。在共102个周期的化疗中,最常见的不良反应为血液学毒性、胃肠道毒性、外周神经毒性,但均以Ⅰ度为主,Ⅲ度迟发性腹泻发生2例次,未出现Ⅳ度不良反应。结论:FFL方案时辰输注法具有疗效高及毒副作用低等优点,可作为晚期胃肠道肿瘤的推荐化疗方案之一。 Objective: To investigate the efficacy and safety of combination of oxaliplatin ( L-OHP), 5-fluorouracil (5-FU) and folinic acid (LV) in form of chronomodulated chemotherapy for advanced gastrointestinal cancer. Methods:Thirty-two patients received a 5-day chronomodulated infusion of L-OHP, 5-FU and LV. L-OHP(25 mg·m^-2·d^-1 ) infused from 10:00 am to 22:00 pm, and followed by 5-FU (600mg·m^-2·d^-1)and LV (300mg·m^-2·d^-1) from 22:00 pm to 10:00 am for 5 days using a muhichannel programmable pump, every 3 weeks as an cycle for at least 2 cycles according to WHO criteria. Results:One complete and 14 partial remissions were observed in all 32 patients with an overall response rate of 46. 9%. Stable disease was observed in 13 patients (40. 6% ) and progressive disease in 4 ( 12.5% ). A total of 102 cycles were given without any grade 4 toxicity observed, The main toxicities were grade 1 bone marrow suppression, toxicitiy of alimentary canal and neurotoxicity, but grade 3 delayed diarrhea in two patients. Conclusion:Chronomodulated intravenous chemotherapy of oxaliplatin, 5-fluororuacil and folinic acid is effective and safe in the treatment of advanced gastrointestinal cancer.
出处 《临床肿瘤学杂志》 CAS 2007年第11期836-838,共3页 Chinese Clinical Oncology
关键词 晚期胃肠道肿瘤 时辰化疗 疗效 毒性反应 Advanced gastrointestinal cancer Chronomodulated chemotherapy Efficacy Toxicities
  • 相关文献

参考文献11

  • 1Kelland L. Broadening the clinical use of platinum drug-based chemotherapy with new analogues. Satraplatin and picoplatin [ J ]. Expert Opin lnvestig Drugs, 2007,16 ( 7 ) : 1009 - 1021.
  • 2Board RE, Valle JW. Metastatic colorectal cancer: current systemic treatment options [ J ]. Drugs, 2007, 67 ( 13 ) : 1851 - 1867.
  • 3Oh SY, Kwon HC, Seo BG,et al. A phase Ⅱ study of oxaliplatin with low dose leucovorin and bolus and continuous infusion 5- fluorouracil (modified FOLFOX-4 ) as first line therapy for patients with advanced gastric cancer [ J ]. Acta Oncol, 2007,46 (3) :336 -341.
  • 4Moon JH, Kim JG, Sohn SK,et al. Outpatient-basis chemotherapy of oxaliplatin, 5-fluorouracil, and leucovorin as first-line treatment for patients with metastatic or recurrent colorectal cancer[J]. J Korean Med Sci, 2007,22(3):400-404.
  • 5Altinok A, L6vi F, Goldbeter A. A cell cycle automaton model for probing circadian patterns of anticancer drug delivery [ J/ OL]. Adv Drug Deliv Rev, 2007, [2007 -08 - 11 ]. http:// www. sciencedirect.com/science? _ob = ArticleURL& udi = B6T3R-4P2SSV8-8&_user = 10&_ coverDate = 08% 2F31% 2F2007&_rdoc = 1 &_fret = &_orig = search&_sort = d&view = c&_acct = C000050211 &_version = 1 & urlVersion = 0&_userid = 10&rod5 = 772 ee3 b215467 c00ddb5195 a94b601 bf.
  • 6Zeng ZL, Sun J, Guo L, et al. Circadian rhythm in dihydropyrimidine dehydrogenase activity and reduced glutathione content in peripheral blood of nasopharyngeal carcinoma patients[ J]. Chronobiol Int, 2005,22(4) :741 -754.
  • 7Balmforth A J, Grant PJ, Scott EM, et al. Inter-subject differences in constitutive expression levels of the clock gene in man [J]. Diab Vasc Dis Res, 2007,4( 1 ) :39 -43.
  • 8Hoogerwerf WA. Biologic clocks and the gut[ J ]. Curr Gastroenterol Rep, 2006, 8(5) :353 -359.
  • 9Farker K, Merkel U, Wedding U, et al. Chronomodulated chemotherapy with oxaliplatin, 5-FU and sodium folinate in metastatic gastrointestinal cancer patients: original analysis of non-hematological toxicity and patient characteristics in a pilot investigation [J]. Int J Clin Pharmacol Ther, 2006,44( 1 ) :31 -37.
  • 10Focan C, Kreutz F, Longree L,et al. Interest of chronotherapy in multidisciplinary management of oesophageal and gastric cancers [J]. Pathol Biol, 2007,55(3 -4) :181-185.

同被引文献17

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部